Mycobacterium Infection Found in Gastric Patients’ Stomachs
|
By LabMedica International staff writers Posted on 26 Nov 2019 |
|
Image: Growth characteristics of rough and smooth phenotypes of Mycobacterium abscessus on 7H11 agar cultured at 37 °C: representative single rough (left) and smooth (right) colonies (Photo courtesy of Hannover Medical School)
Development of gastric diseases such as gastritis, peptic ulcer and gastric cancer is often associated with several biotic and abiotic factors. Helicobacter pylori infection is such a well-known biotic factor. However, not all H. pylori-infected individuals develop gastric diseases and not all individuals with gastric diseases are infected with H. pylori.
H. pylori is not the only bacterium that can colonize human stomach. Culture independent metagenomic sequence analyses have shown that human stomach carries a unique microbiota. The dominant phyla that are present in human stomach are Proteobacteria, Firmicutes, Actinobacteria and Fusobacterium. Interestingly, however, most of these bacteria cannot be cultured using traditional techniques.
Microbiologists at the Rajiv Gandhi Centre for Biotechnology (Thiruvananthapuram, India) recruited patients aged between 20 and 70 with various gastric and esophageal symptoms ranging from mild dyspepsia, gastro-esophageal reflux disorder to severe gastric diseases like gastric cancer and who were recommended to have upper gastrointestinal endoscopy. Three gastric biopsy specimens were collected from each patient for this study. The aim of this study was to isolate prevalent gastric bacteria under microaerobic condition and identify them by 16S rRNA gene sequence analysis.
The team employed various technologies including gastric bacteria culture, bacterial DNA isolation, extraction of intracellular bacterial DNA from biopsy tissues, molecular characterization of the bacteria isolated from stomach. The purified DNA fragments were sequenced by a 3730XL DNA analyzer (Thermo Fisher Scientific, Waltham, Massachusetts, USA). The team also performed Hematoxylin and Eosin (H&E) and Ziehl-Neelsen Acid-fast staining on tissue biopsies, and immunohistochemistry.
Analysis of gastric biopsies showed infection of Mycobacterium abscessus (phylum Actinobacteria) to be highly prevalent in the stomachs of subjects included. The data showed that of 129 (67 male and 62 female) patients with gastric symptoms, 96 (51 male and 45 female) showed the presence of M. abscessus in stomach tissues. Infection of M. abscessus in gastric epithelium was further confirmed by imaging with acid fast staining, immunohistochemistry and immunofluorescence. Surprisingly, the subjects studied, the prevalence of M. abscessus infection in stomach is even higher than the prevalence of H. pylori infection.
The authors concluded that their study on 129 individuals with gastric diseases shows that the prevalence of gastric M. abscessus is higher in the local population as compared to the prevalence of H. pylori. The route of transmission is not known at present, but water could be a source. Significance of this infection is also presently unknown, but it may have a significant role in the formation or progression of gastric disease. The study was published on November 4, 2019 in the journal PLOS Neglected Tropical Diseases.
Related Links:
Rajiv Gandhi Centre for Biotechnology
Thermo Fisher Scientific
H. pylori is not the only bacterium that can colonize human stomach. Culture independent metagenomic sequence analyses have shown that human stomach carries a unique microbiota. The dominant phyla that are present in human stomach are Proteobacteria, Firmicutes, Actinobacteria and Fusobacterium. Interestingly, however, most of these bacteria cannot be cultured using traditional techniques.
Microbiologists at the Rajiv Gandhi Centre for Biotechnology (Thiruvananthapuram, India) recruited patients aged between 20 and 70 with various gastric and esophageal symptoms ranging from mild dyspepsia, gastro-esophageal reflux disorder to severe gastric diseases like gastric cancer and who were recommended to have upper gastrointestinal endoscopy. Three gastric biopsy specimens were collected from each patient for this study. The aim of this study was to isolate prevalent gastric bacteria under microaerobic condition and identify them by 16S rRNA gene sequence analysis.
The team employed various technologies including gastric bacteria culture, bacterial DNA isolation, extraction of intracellular bacterial DNA from biopsy tissues, molecular characterization of the bacteria isolated from stomach. The purified DNA fragments were sequenced by a 3730XL DNA analyzer (Thermo Fisher Scientific, Waltham, Massachusetts, USA). The team also performed Hematoxylin and Eosin (H&E) and Ziehl-Neelsen Acid-fast staining on tissue biopsies, and immunohistochemistry.
Analysis of gastric biopsies showed infection of Mycobacterium abscessus (phylum Actinobacteria) to be highly prevalent in the stomachs of subjects included. The data showed that of 129 (67 male and 62 female) patients with gastric symptoms, 96 (51 male and 45 female) showed the presence of M. abscessus in stomach tissues. Infection of M. abscessus in gastric epithelium was further confirmed by imaging with acid fast staining, immunohistochemistry and immunofluorescence. Surprisingly, the subjects studied, the prevalence of M. abscessus infection in stomach is even higher than the prevalence of H. pylori infection.
The authors concluded that their study on 129 individuals with gastric diseases shows that the prevalence of gastric M. abscessus is higher in the local population as compared to the prevalence of H. pylori. The route of transmission is not known at present, but water could be a source. Significance of this infection is also presently unknown, but it may have a significant role in the formation or progression of gastric disease. The study was published on November 4, 2019 in the journal PLOS Neglected Tropical Diseases.
Related Links:
Rajiv Gandhi Centre for Biotechnology
Thermo Fisher Scientific
Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Silver Member
Vitamin D Assay
EZ Vitamin D Assay
Gold Member
Platelet Function Analyzer
PL-12
Latest Molecular Diagnostics News
- RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer
- Modeling Study Shows Blood-Based CRC Screening Could Prevent More Deaths Than Stool Tests
- Noninvasive Cervical Test Detects Endometrial Cancer for Triage
- AI Tool Classifies Pathogenic Variants in Severe Childhood Epilepsy
- Molecular Test Detects Barrett’s Esophagus to Guide Endoscopy Referral
- Blood-Based Metagenomic Test Detects Wide Range of Pathogens from Single Sample
- New RNA Detection Tool Shows Promise for HIV and Other Viral Testing
- Tissue-Specific Vesicle Isolation Expands Molecular Insights Into Liver Disease
- Whole Genome Sequencing Solution Targets Unsolved Rare Disease Cases
- Validated Test Predicts Recurrence Risk and Radiation Benefit in Early-Stage Breast Cancer
- Study Shows How Genome Reference Bias Can Mislead Preventive Testing
- Genomic Screening Expands Detection of Treatable Conditions in Newborns
- Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants
- Pooled Sputum Testing Offers Lower-Cost Molecular Diagnosis for Tuberculosis
- Expanded Sequencing Panel Supports Myeloid Malignancy Variant Profiling
- Tumor Markers Help Predict Response to Less Intensive HER2+ Chemotherapy
Channels
Clinical Chemistry
view channel
New One-Step Syphilis Test Could Enable Earlier Detection and Faster Treatment
Syphilis can be difficult to diagnose because its symptoms may resemble other diseases and appear and disappear without treatment. Undetected infection can continue causing harm, spread to partners and... Read more
Multimodal Clinical Data Models Predict Cachexia Risk Across Cancers
Cancer cachexia is a severe wasting syndrome that affects roughly half of patients with cancer and cannot be reversed simply by increasing food intake. It can reduce treatment tolerance, impair quality... Read more
Molecular Diagnostics
view channel
RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more
Modeling Study Shows Blood-Based CRC Screening Could Prevent More Deaths Than Stool Tests
Colorectal cancer (CRC) screening depends on patient participation and completion of follow-up colonoscopy after an abnormal noninvasive result. Access barriers can make both steps difficult, particularly... Read more
Hematology
view channel
New Myelofibrosis Guidelines Recommend Expanded Genetic Testing at Diagnosis
Myelofibrosis is a rare, life-threatening blood cancer affecting up to six per 100,000 people. The disease causes scarring in the bone marrow, limiting the production of healthy blood cells and potentially... Read more
Handheld Point-of-Care Test Aims to Enable Rapid Coagulation Assessment in Trauma
Severe blood loss and inadequate tissue oxygenation are leading causes of preventable death after traumatic injury. Blood products are essential in trauma care, but cold-chain storage, short shelf life,... Read more
Immunology
view channel
Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk
A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more
Longitudinal Blood Testing Reveals Changes in Allergen Sensitization During Childhood
Food allergy is a major childhood health concern, and distinguishing persistent risk from transient sensitization can guide clinical decisions. Specific IgE antibodies may be detectable even when a child... Read more
Pathology
view channel
Molecular Testing Refines Barrett’s Esophagus Progression Risk Beyond Biopsy Findings
Barrett’s esophagus is a precancerous condition associated with increased risk of esophageal adenocarcinoma. Routine endoscopic biopsy findings guide surveillance and therapy, but histopathology may not... Read more
Updated Digital Pathology Platform Expands AI Integration for Cancer Diagnosis
Digital pathology is reshaping how laboratories manage case review, image analysis, and collaboration. As diagnostic workflows become more complex, pathology teams need platforms that can support digital... Read more
Technology
view channel
Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns
Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more
Laser-Enhanced Assay Boosts Sensitivity for Colorectal Cancer Biomarker Detection
Colorectal cancer is the third most commonly diagnosed cancer and the second leading cause of cancer-related death worldwide. Early detection remains critical, but cancer biomarkers can produce only faint... Read more
Industry
view channel
Expanded Partnership Scales AI-Powered Digital Pathology for Oncology
Oncology diagnostics rely on pathology and biomarker information to guide personalized treatment. As computational pathology and artificial intelligence (AI) expand insights from tissue analysis, laboratories... Read more
Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care
Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
